Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020223657 - SOMATIC CANCER DRIVER MUTATIONS IN ENDOMETRIOSIS LESIONS CONTRIBUTE TO SECONDARY CANCER RISK

Publication Number WO/2020/223657
Publication Date 05.11.2020
International Application No. PCT/US2020/031089
International Filing Date 01.05.2020
IPC
C12Q 1/68 2018.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
G01N 33/574 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
Applicants
  • PREDICTIVE TECHNOLOGY GROUP, INC. [US]/[US]
Inventors
  • WARD, Kenneth
Agents
  • ARONIN, Caren P.
Priority Data
62/842,06002.05.2019US
62/842,06102.05.2019US
62/842,06402.05.2019US
62/842,06602.05.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) SOMATIC CANCER DRIVER MUTATIONS IN ENDOMETRIOSIS LESIONS CONTRIBUTE TO SECONDARY CANCER RISK
(FR) CONTRIBUTION À UN RISQUE DE CANCER SECONDAIRE DE MUTATIONS SOMATIQUES DE FACTEURS DU CANCER DANS LES LÉSIONS D'ENDOMÉTRIOSE
Abstract
(EN)
Disclosed herein are methods of diagnosing one or more conditions, including endometriosis, cancer, or a combination thereof. The methods may also include identifying a likelihood or risk of developing one or more conditions. Disclosed herein are methods and compositions for treating one or more conditions, such as by administering one or more pharmaceutical compositions in unit dose form. The treating may include prophylactic treating. Methods may include detecting one or more mutations in a genetic material obtained from a subject, such as a subject in need thereof.
(FR)
L'invention concerne des méthodes de diagnostic d'une ou plusieurs pathologies, comprenant l'endométriose, le cancer, ou une combinaison de ceux-ci. Les méthodes peuvent également comprendre l'identification d'une probabilité ou d'un risque de développer une ou plusieurs pathologies. L'invention concerne des méthodes et des compositions pour le traitement d'une ou plusieurs pathologies, par exemple par administration d'une ou plusieurs compositions pharmaceutiques sous la forme de doses unitaires. Le traitement peut comprendre un traitement prophylactique. Les méthodes peuvent comprendre la détection d'une ou plusieurs mutations dans un matériau génétique prélevé chez un sujet, par exemple un sujet en ayant besoin.
Latest bibliographic data on file with the International Bureau